IT1153182B - Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano - Google Patents

Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano

Info

Publication number
IT1153182B
IT1153182B IT8223017A IT2301782A IT1153182B IT 1153182 B IT1153182 B IT 1153182B IT 8223017 A IT8223017 A IT 8223017A IT 2301782 A IT2301782 A IT 2301782A IT 1153182 B IT1153182 B IT 1153182B
Authority
IT
Italy
Prior art keywords
human
peptide
pharmaceutical formulations
formulations including
human insulin
Prior art date
Application number
IT8223017A
Other languages
English (en)
Italian (it)
Other versions
IT8223017A0 (it
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IT8223017A0 publication Critical patent/IT8223017A0/it
Application granted granted Critical
Publication of IT1153182B publication Critical patent/IT1153182B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IT8223017A 1981-08-27 1982-08-27 Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano IT1153182B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
IT8223017A0 IT8223017A0 (it) 1982-08-27
IT1153182B true IT1153182B (it) 1987-01-14

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8223017A IT1153182B (it) 1981-08-27 1982-08-27 Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano

Country Status (20)

Country Link
JP (1) JPS5846024A (xx)
AU (1) AU551879B2 (xx)
BE (1) BE894185A (xx)
CA (1) CA1176158A (xx)
CH (1) CH650679A5 (xx)
DE (1) DE3232034A1 (xx)
DZ (1) DZ452A1 (xx)
FR (1) FR2513126B1 (xx)
GB (1) GB2104382B (xx)
IE (1) IE54119B1 (xx)
IL (1) IL66611A0 (xx)
IT (1) IT1153182B (xx)
LU (1) LU84359A1 (xx)
MW (1) MW3882A1 (xx)
NL (1) NL192192C (xx)
NZ (1) NZ201682A (xx)
PH (1) PH19361A (xx)
SE (1) SE460334B (xx)
ZA (1) ZA826159B (xx)
ZW (1) ZW17482A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
EP0280534B1 (en) * 1987-02-25 1993-04-21 Novo Nordisk A/S Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
US8263551B2 (en) 2004-11-22 2012-09-11 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
JP5765813B2 (ja) 2008-09-19 2015-08-19 ウェルズ ファーゴ バンク ナショナル アソシエイション 治療用ペプチドのポリマーコンジュゲート
WO2011146518A2 (en) 2010-05-17 2011-11-24 Cebix Inc. Pegylated c-peptide
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
CH650679A5 (de) 1985-08-15
SE460334B (sv) 1989-10-02
FR2513126A1 (fr) 1983-03-25
NZ201682A (en) 1985-08-16
NL192192C (nl) 1997-03-04
GB2104382B (en) 1984-12-19
JPS5846024A (ja) 1983-03-17
MW3882A1 (en) 1984-07-11
IT8223017A0 (it) 1982-08-27
DE3232034C2 (xx) 1991-04-11
SE8204873L (sv) 1983-02-28
NL192192B (nl) 1996-11-01
AU8759482A (en) 1983-03-03
CA1176158A (en) 1984-10-16
IE822064L (en) 1983-02-27
DZ452A1 (fr) 2004-09-13
AU551879B2 (en) 1986-05-15
DE3232034A1 (de) 1983-03-10
ZW17482A1 (en) 1982-11-17
IE54119B1 (en) 1989-06-21
LU84359A1 (fr) 1983-02-28
ZA826159B (en) 1984-04-25
GB2104382A (en) 1983-03-09
SE8204873D0 (sv) 1982-08-25
FR2513126B1 (fr) 1986-04-18
PH19361A (en) 1986-04-02
BE894185A (fr) 1983-02-24
NL8203315A (nl) 1983-03-16
IL66611A0 (en) 1982-12-31

Similar Documents

Publication Publication Date Title
IT1218469B (it) Polipeptide umano fisiologicamente ettivo
IT1153182B (it) Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano
IT1153181B (it) Formulazioni farmaceutiche comprendenti insulina umana e proinsulina umana
DK13990D0 (da) Superaktive humane insulinanaloge
IL66610A0 (en) Human proinsulin pharmaceutical formulations
ZW17682A1 (en) Pharmaceutical formulations comprising human insulin human c-peptide and human proinsulin
JO1236B1 (en) Pharmacy formulations that include human insulin and a human-c-peptide
JO1238B1 (en) Pharmacy formulations include human insulin, human peptide-C and the human insulin component
JO1209B1 (en) Pharmacy formulations that include human insulin and the human insulin component.
BE885510A (fr) Medicament omni-potent dans la therapeutique contre la sclerose en plaque et l'arterio-sclerose
IE812104L (en) Novel insulin formulations based on human insulin
RO88841A2 (ro) Medicament de uz stomatologic

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970717